
Mindset Pharma
Pioneering next-generation psychedelic medicines for neurological and psychiatric disorders.
Market cap
$56.5m
Enterprise value
$51m
Share price
€0.49 9DF.F
Authorizing premium user...
Pioneering next-generation psychedelic medicines for neurological and psychiatric disorders.